(Q38168923)

30 August 2017

title

The current position and the future perspectives of cervical cancer screening (English)

1 reference

30 August 2017

main subject

cervix uterine cancer

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308681%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Albert Siebers Siebers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308681%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Johan Bulten

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308681%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Willem Melchers

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308681%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Remko P Bosgraaf

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308681%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Joanne A De Hullu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308681%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Leon F A G Massuger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308681%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Ruud L M Bekkers

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308681%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

publication date

28 November 2013

1 reference

Expert Review of Anticancer Therapy

30 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308681%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308681%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308681%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

75-92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308681%20AND%20SRC:MED&resulttype=core&format=json

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

10 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

The biology and life-cycle of human papillomaviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

A review of human carcinogens--Part B: biological agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

The causal relation between human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Epidemiology of Genital Human Papillomavirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Human papillomavirus detection: testing methodologies and their clinical utility in cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Updating the natural history of human papillomavirus and anogenital cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Global burden of human papillomavirus and related diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Comparisons of cervical cancer screening programmes in the European Union

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Patients with cervical cancer: why did screening not prevent these cases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Barriers to cervical cancer screening attendance in England: a population-based survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Inequalities in reported use of breast and cervical screening in Great Britain: analysis of cross sectional survey data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Cognition and affect after cervical screening: the role of previous test outcome and personal obligation in future uptake expectations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Reasons for non-attendance in cervical cancer screening programmes: an application of the Integrated Model for Behavioural Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Cancer prevention in primary care. Screening for cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

HPV testing on self collected cervicovaginal lavage specimens as screening method for women who do not attend cervical screening: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Predicting mortality from cervical cancer after negative smear test results

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Reframing cervical cancer prevention. Expanding the field towards prevention of human papillomavirus infections and related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Assessment of manual workload limits in gynecologic cytology: reconciling data from 3 major prospective trials of automated screening devices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Comparison of computer-assisted and manual screening of cervical cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Accuracy of several cervical screening strategies for early detection of cervical cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

New technologies and procedures for cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Validation of high-risk HPV tests for primary cervical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Nucleic acid tests for the detection of alpha human papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Triage of HPV-positive women in cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Cervical cancer screening: what's new and what's coming?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

A framework provided an outline toward the proper evaluation of potential screening strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Management of women who test positive for high-risk types of human papillomavirus: the HART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Primary cervical cancer screening with HPV testing compared with liquid-based cytology: results of round 1 of a randomised controlled trial -- the HPV FOCAL Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Primary human papillomavirus testing in organized cervical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Human papillomavirus testing and genotyping in cervical screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Clinical utility of HPV genotyping

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Papillomavirus E6 and E7 proteins and their cellular targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

The natural history of cervical HPV infection: unresolved issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

p16INK4a immunocytochemistry versus human papillomavirus testing for triage of women with minor cytologic abnormalities: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Risk of high-grade cervical intraepithelial neoplasia during follow-up in HPV-positive women according to baseline p16-INK4A results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Automated detection of dual p16/Ki67 nuclear immunoreactivity in liquid-based Pap tests for improved cervical cancer risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Performance of ProEx C and PreTect HPV-Proofer E6/E7 mRNA tests in comparison with the hybrid capture 2 HPV DNA test for triaging ASCUS and LSIL cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Direct human papillomavirus E6 whole-cell enzyme-linked immunosorbent assay for objective measurement of E6 oncoproteins in cytology samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

An evaluation of novel, lower-cost molecular screening tests for human papillomavirus in rural China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Detection of Genomic Amplification of the Human Telomerase Gene (TERC) in Cytologic Specimens as a Genetic Test for the Diagnosis of Cervical Dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

3q26 amplification is an effective negative triage test for LSIL: a historical prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Amplification of the chromosome 3q26 region shows high negative predictive value for nonmalignant transformation of LSIL cytologic finding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Role of chromosome 3q26 gain in predicting progression of cervical dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

The potential role of self-sampling for high-risk human papillomavirus detection in cervical cancer screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Diagnostic accuracy of self collected vaginal specimens for human papillomavirus compared to clinician collected human papillomavirus specimens: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Dry storage and transport of a cervicovaginal self-sample by use of the Evalyn Brush, providing reliable human papillomavirus detection combined with comfort for women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

A cross-sectional study on the acceptability of self-collection for HPV testing among women in rural China

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Brush-based self-sampling in combination with GP5+/6+-PCR-based hrHPV testing: high concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

High concordance of results of testing for human papillomavirus in cervicovaginal samples collected by two methods, with comparison of a novel self-sampling device to a conventional endocervical brush

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

The Peru Cervical Cancer Prevention Study (PERCAPS): the technology to make screening accessible.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

The Mexican Cervical Cancer Screening Trial: self-sampling for human papillomavirus with unaided visual inspection as a secondary screen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Type-specific human papillomavirus DNA testing with the genotyping array: a comparison of cervical and vaginal sampling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Self-collected samples for testing of oncogenic human papillomavirus: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

Screening history of women with invasive cervical cancer in north-east Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273

BD-ProExC as Adjunct Molecular Marker for Improved Detection of CIN2+ after HPV Primary Screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.2014.856273